CAYA Cancer Retrospective Cohort Study
Recruiting
Observational Study
Acute Lymphoblastic Leukemia
Lymphoblastic Lymphoma
Young Adult Cancer
Adolescent Cancer
Childhood Cancers
Acute Lymphoblastic Leukemia (ALL)
Lymphoblastic Lymphoma (LBL)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 0 – 21
- Sex
- Any
- Study type
- Observational
- Participants needed
- 18,000 (estimated)
- Sponsor
- Resonance, Inc. · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Despite advances in cancer treatment, significant disparities in outcomes persist between high-income countries (HICs) and low-and middle-income countries (LMICs). Around 80% of children with cancer live in LMICs, where they face challenges such as delayed diagnosis, misdiagnosis, comorbidities, distance to treatment, financial barriers, and limited access to risk-adapted therapies.
Acute lymphob…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Subjects must meet all the following criteria to be included in this registry:
1. Participants must be willing and able to provide informed consent prior to enrollment in the registry.
1. For minors or individuals unable to provide informed consent, assent must be obtained …
Contacts